TSS
CLRB icon

Two Sigma Securities’s Cellectar Biosciences CLRB Stock Holding History

Two Sigma Securities’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,732
Closed -$15.5K – 1553
2024
Q4 		$15.5K Buy
1,732
+972
+128% +$44.9K ﹤0.01% 1362
2024
Q3 		$48.8K Buy
+760
New +$50.1K ﹤0.01% 2379
2022
Q1 		– Sell
-47
Closed -$9K – 2151
2021
Q4 		$9K Sell
47
-37
-44% -$8.91K ﹤0.01% 1483
2021
Q3 		$23K Buy
+84
New +$25.6K ﹤0.01% 1452
2018
Q3 		– Sell
-11
Closed -$20K – 2627
2018
Q2 		$20K Sell
11
-1
-8% -$3.07K ﹤0.01% 2560
2018
Q1 		$41K Buy
12
+7
+140% +$25K ﹤0.01% 2521
2017
Q4 		$19K Buy
5
+2
+67% +$8.94K ﹤0.01% 1629
2017
Q3 		$18K Buy
+3
New +$14.5K ﹤0.01% 836

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Securities's CLRB Position: Q1 2025 in Review

Two Sigma Securities sold out of Cellectar Biosciences (CLRB) in Q1 2025, closing a stake of 1,732 shares — an estimated $15.5K sold.

Two Sigma Securities first reported a position in CLRB in Q3 2017 and held it in 8 quarters. The position peaked at $48.8K in Q3 2024. 32 funds tracked by Wall St. Rank hold CLRB as of Q1 2025.

  • Two Sigma Securities reported no remaining Cellectar Biosciences position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,732 Cellectar Biosciences shares in Q1 2025, an estimated $15.5K.
  • Two Sigma Securities first reported a position in Cellectar Biosciences in Q3 2017 and held it in 8 quarters.
  • Two Sigma Securities's Cellectar Biosciences position peaked at $48.8K in Q3 2024.
  • 32 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.